Cost-Utility Analysis of Genetic Screening in Families of Patients With Germline MUTYH Mutations

BMC Medical Genetics - United Kingdom
doi 10.1186/1471-2350-8-42
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Germline MUTYH Gene Mutations Are Not Frequently Found in Unselected Patients With Papillary Breast Carcinoma

Hereditary Cancer in Clinical Practice
OncologyGenetics
2014English

Valuing Cost in Cost Utility Analysis of Screening Programme

Journal of Medical Screening
Health PolicyPublic HealthOccupational HealthEnvironmental
2004English

Cost-Utility Analysis of Nonalcoholic Steatohepatitis Screening

European Radiology
MedicineNuclear MedicineRadiologyImaging
2015English

Tracking Tumor Kinetics in Patients With Germline CYLD Mutations

Journal of the American Academy of Dermatology
Dermatology
2018English

Pcn195 - Cost-Utility Analysis of the Germline Brca Testing in Women With Epithelial Ovarian Cancer Without Family History in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer

Gastroenterology
HepatologyGastroenterology
2015English

Analytical Representation of Utility Functions for Cervical Screening Strategies in Their Evaluation With “Cost-Utility” Method

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Germline CDKN2A /P16ink4a Mutations Contribute to Genetic Determinism of Sarcoma

Journal of Medical Genetics
Genetics
2017English

Cost-Utility Analysis of Supported Self-Management With Motiva­tional Interviewing for Patients With Psoriasis

Acta Dermato-Venereologica
DermatologyMedicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy